JAHA:蒽环类药物对左心室射血分数的心脏毒性效应

2021-03-05 MedSci原创 MedSci原创

蒽环类药物治疗后LVEF损伤的程度似乎比先前描述的当代化疗方案要小。

蒽环类药物是血液系统和实体恶性肿瘤关键的化学治疗剂。然而,它们对癌症生存的益处受到累积的、剂量相关心脏毒性的限制。在当代化疗方案中,蒽环类药物对左心室射血分数(LVEF)的影响尚未明确。

近日,血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员系统地检索了三个数据库(CENTRAL、MEDLINE和SCOPUS)以确定评估心脏保护剂与与安慰剂相比对心脏毒性预防作用的随机试验。研究人员从安慰剂试验组中提取了蒽环类药物化疗前后基于超声心动图或磁共振检查评估的LVEF。

该研究检索的关键词包括“蒽环类”、“心脏毒性”和“随机化”。研究人员计算了阿霉素当量蒽环类药物剂量度量以比较不同的蒽环类药物。随机效应模型用于合并蒽环类药物治疗后LVEF的平均差异。研究人员通过计算Neta回归来确定变异源。

研究人员纳入了19项试验的660名患者。各项研究基线的加权平均LVEF为62.6%,在6个月时对LVEF进行了随访评估。安慰剂组LVEF平均下降为5.4%(95%CI为3.5%–7.3%),蒽环类药物的阿霉素当量为385 mg/m2。Meta回归分析发现蒽环类药物阿霉素当量作为连续变量(P=0.29)或已发表的心脏毒性临界值(250 mg/m2,P=0.21;360 mg/m2,P=0.40; 400 mg/m2,P=0.66)时LVEF无显著差异。LVEF的平均差异与性别、辅助化疗或癌症类型无关。

由此可见,蒽环类药物治疗后LVEF损伤的程度似乎比先前描述的当代化疗方案要小

原始出处:

Prajith Jeyaprakash.et al.Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials.J AM HEART ASSOC.2021.https://www.ahajournals.org/doi/full/10.1161/JAHA.120.018802

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1674758, encodeId=c23016e4758ed, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Mon Nov 22 01:44:40 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268447, encodeId=7330126844ee6, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413293, encodeId=58d814132936e, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418123, encodeId=5ab9141812311, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521708, encodeId=8f0e1521e0896, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945828, encodeId=2a2e9458289d, content=好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210305/d89c73f794ef4213beffed169c66fa7c/b18031d827534a0db9fdd1ed7f6f78d5.jpg, createdBy=28865465978, createdName=ms7000001357480273, createdTime=Fri Mar 05 20:44:04 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945792, encodeId=44ba945e92cb, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 05 17:59:14 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1674758, encodeId=c23016e4758ed, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Mon Nov 22 01:44:40 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268447, encodeId=7330126844ee6, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413293, encodeId=58d814132936e, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418123, encodeId=5ab9141812311, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521708, encodeId=8f0e1521e0896, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945828, encodeId=2a2e9458289d, content=好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210305/d89c73f794ef4213beffed169c66fa7c/b18031d827534a0db9fdd1ed7f6f78d5.jpg, createdBy=28865465978, createdName=ms7000001357480273, createdTime=Fri Mar 05 20:44:04 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945792, encodeId=44ba945e92cb, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 05 17:59:14 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-07 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=1674758, encodeId=c23016e4758ed, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Mon Nov 22 01:44:40 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268447, encodeId=7330126844ee6, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413293, encodeId=58d814132936e, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418123, encodeId=5ab9141812311, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521708, encodeId=8f0e1521e0896, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945828, encodeId=2a2e9458289d, content=好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210305/d89c73f794ef4213beffed169c66fa7c/b18031d827534a0db9fdd1ed7f6f78d5.jpg, createdBy=28865465978, createdName=ms7000001357480273, createdTime=Fri Mar 05 20:44:04 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945792, encodeId=44ba945e92cb, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 05 17:59:14 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1674758, encodeId=c23016e4758ed, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Mon Nov 22 01:44:40 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268447, encodeId=7330126844ee6, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413293, encodeId=58d814132936e, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418123, encodeId=5ab9141812311, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521708, encodeId=8f0e1521e0896, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945828, encodeId=2a2e9458289d, content=好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210305/d89c73f794ef4213beffed169c66fa7c/b18031d827534a0db9fdd1ed7f6f78d5.jpg, createdBy=28865465978, createdName=ms7000001357480273, createdTime=Fri Mar 05 20:44:04 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945792, encodeId=44ba945e92cb, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 05 17:59:14 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1674758, encodeId=c23016e4758ed, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Mon Nov 22 01:44:40 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268447, encodeId=7330126844ee6, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413293, encodeId=58d814132936e, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418123, encodeId=5ab9141812311, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521708, encodeId=8f0e1521e0896, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945828, encodeId=2a2e9458289d, content=好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210305/d89c73f794ef4213beffed169c66fa7c/b18031d827534a0db9fdd1ed7f6f78d5.jpg, createdBy=28865465978, createdName=ms7000001357480273, createdTime=Fri Mar 05 20:44:04 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945792, encodeId=44ba945e92cb, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 05 17:59:14 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1674758, encodeId=c23016e4758ed, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Mon Nov 22 01:44:40 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268447, encodeId=7330126844ee6, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413293, encodeId=58d814132936e, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418123, encodeId=5ab9141812311, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521708, encodeId=8f0e1521e0896, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945828, encodeId=2a2e9458289d, content=好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210305/d89c73f794ef4213beffed169c66fa7c/b18031d827534a0db9fdd1ed7f6f78d5.jpg, createdBy=28865465978, createdName=ms7000001357480273, createdTime=Fri Mar 05 20:44:04 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945792, encodeId=44ba945e92cb, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 05 17:59:14 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 ms7000001357480273

    好文

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1674758, encodeId=c23016e4758ed, content=<a href='/topic/show?id=3c7c4804309' target=_blank style='color:#2F92EE;'>#左心室射血分数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48043, encryptionId=3c7c4804309, topicName=左心室射血分数)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036327112999, createdName=yourmama, createdTime=Mon Nov 22 01:44:40 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268447, encodeId=7330126844ee6, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413293, encodeId=58d814132936e, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418123, encodeId=5ab9141812311, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521708, encodeId=8f0e1521e0896, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Sun Mar 07 07:44:40 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945828, encodeId=2a2e9458289d, content=好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210305/d89c73f794ef4213beffed169c66fa7c/b18031d827534a0db9fdd1ed7f6f78d5.jpg, createdBy=28865465978, createdName=ms7000001357480273, createdTime=Fri Mar 05 20:44:04 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945792, encodeId=44ba945e92cb, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 05 17:59:14 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 jyzxjiangqin

    好文章!

    0

相关资讯

这种肿瘤治疗相关心脏损伤死亡率高!阜外学者综述

免疫检查点抑制剂如针对细胞毒T淋巴细胞相关抗原4(CTLA-4)、程序性死亡受体-1(PD-1)及其配体的单克隆抗体治疗已成为越来越多肿瘤的标准治疗,越来越多的患者应用这些药物的同时出现免疫相关副反应

JAHA:乳腺癌患者心脏毒性和心血管生物标志物

NT-proBNP和血红蛋白与接受剂量强化化疗的早期乳腺癌患者的心脏毒性反应显著相关,而高敏心脏肌钙蛋白T则不然。

Eur Heart J:抗癌治疗引起的心脏毒性分类、患病率和结局

由此可见,大多数患者在癌症治疗期间或之后出现了心肌损伤/功能障碍的客观数据。但是,严重的CTox具有很强的预后关系,发生相对较少。

JACC:Ibrutinib药物会出现严重的心脏毒性反应

Ibrutinib药物对于严重B淋巴细胞瘤的治疗来说是一场革命,然而近期的临床试验结果显示Ibrutinib会增加患者的死亡风险,其中心源性毒性被认为是罪魁祸首。本研究的目的旨在评估Ibrutinib药物相关的心血管毒性反应(CV-ADR)。本研究发现了303例Ibrutinib药物相关性死亡,Ibrutinib与更高的室上性心律失常(SVAs)相关(ROR: 23.1; 95% cl: 21.6

Clin Cancer Res:3期试验| 阿霉素治疗对晚期软组织肉瘤患者的心脏毒性

阿霉素治疗对晚期软组织肉瘤患者的心脏毒性

Hesperos的芯片可模拟药物在人体内心脏和肝脏毒性,未来可用于预测临床结果

发表在Nature Scientific Reports杂志上最新研究显示,Hesperos 公司的"human-on-a-chip"芯片装置通过模拟心脏和肝脏,可以测量两种已知的可可损害心脏的小分子药物浓度和代谢,并能够提供对人体毒性的准确数据。